Lilly's obesity pill records modest second week as battle with Novo intensifies
Summary
By Sriparna Roy April 24 (Reuters) - Eli Lilly's newly launched weight-loss pill had a modest second week, analysts said on Friday, as competition with Danish rival Novo Nordisk heats up in the oral
Description
By Sriparna Roy April 24 (Reuters) - Eli Lilly's newly launched weight-loss pill had a modest second week, analysts said on Friday, as competition with Danish rival Novo Nordisk heats up in the oral
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source